Teplizumab drug to delay type 1 diabetes to be rolled out on the NHS
The NHS will begin rolling out Teplizumab, a disease-modifying therapy designed to delay the onset of type 1 diabetes.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
The NHS has approved the use of Teplizumab, also known as Tzield, to slow the progression of type 1 diabetes. This treatment represents the first of its kind to be offered via the UK's national health service to delay the start of the disease.
Coverage from the BBC, The Sun, and Diabetes UK emphasizes the drug's role as a breakthrough in treatment. The Times reports that the medication will delay the onset of the disease by three years, while Citeline News & Insights notes that England is leading Europe in reimbursing the Sanofi-developed therapy.
Future developments center on the rollout of the therapy across the NHS and its implementation as a disease-modifying treatment in England.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 1d ago.
Quick answers
What is Teplizumab?
It is a disease-modifying therapy, also known as Tzield, used to slow or delay the onset of type 1 diabetes.
How much does it delay the disease?
According to The Times, the drug will delay the onset by three years.
Which organization developed the drug?
The therapy was developed by Sanofi.
Coverage (8)
- Experts hail ‘new age of diabetes treatment’ as drug approved on NHS The Independent · 1d ago
- Drug that delays type 1 diabetes approved for NHS The Telegraph · 1d ago
- Drug that delays onset of type 1 diabetes approved in England and Wales The Guardian · 1d ago
- Breakthrough in type 1 diabetes as drug offered on NHS delays start of disease The Sun · 1d ago
- Teplizumab, the first treatment to slow type 1 diabetes, approved for use on the NHS Diabetes UK · 1d ago
- England Leads Europe In Reimbursing Sanofi’s Type 1 Diabetes Disease-Modifying Therapy Tzield Citeline News & Insights · 1d ago
- Type 1 diabetes drug will delay onset by three years The Times · 1d ago
- Teplizumab drug to delay type 1 diabetes to be rolled out on the NHS BBC · 1d ago
Topics
Related trends
Thousands of men with prostate cancer will now be offered high-powered radiotherapy on the NHS
The NHS is expanding access to a new radiotherapy treatment for prostate cancer